HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in AJPH Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khoury, M J Search for Related Content PubMed PubMed Citation Articles by Khoury, M J

From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group.

M J Khoury

Birth Defects and Genetics Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA.

OBJECTIVES: With advances in the Human Genome Project, the implications of genetic technology in disease prevention should be assessed. METHODS: The paradigm suggested in The Future of Public Health--assessment, policy development, and assurance--was used to examine the continuum from genetic technology to public health practice. RESULTS: First, important public health functions are to (1) assess the impact of genes and their interactions with modifiable disease risk factors on the health status of the population and (2) assess the impact and safety of genetic testing on the population. Second, given the many implications of genetic testing, the public health community should participate in policy development related to the timing and use of genetic testing in disease prevention. Third, whenever appropriate, the public health community needs to ensure the development of public health genetics programs (e.g. newborn screening) and evaluate the quality and effectiveness of the use of genetic testing in disease prevention. CONCLUSIONS: Although most current genetic tests are not ready for disease prevention, there is an important role for the public health community in translating genetic technology into disease prevention.

Related articles in AJPH:

Comment: genetics and public health.

G S Omenn
AJPH 1996 86: 1701-1704. [PDF]  

This article has been cited by other articles:

				A. Petersen The genetic conception of health: is it as radical as claimed? Health (London) , October 1, 2006; 10(4): 481 - 500. [Abstract] [PDF]

				K G Fulda and K Lykens Ethical issues in predictive genetic testing: a public health perspective. J. Med. Ethics, March 1, 2006; 32(3): 143 - 147. [Abstract] [Full Text] [PDF]

				H. Brand Public health genetics--potential for public health? Eur J Public Health, April 1, 2005; 15(2): 112 - 112. [Full Text] [PDF]

				K. R. Merikangas and N. Risch Genomic Priorities and Public Health Science, October 24, 2003; 302(5645): 599 - 601. [Abstract] [Full Text] [PDF]

				F. P. Perera, L. A. Mooney, M. Stampfer, D. H. Phillips, D. A. Bell, A. Rundle, S. Cho, W.-Y. Tsai, J. Ma, A. Blackwood, et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study Carcinogenesis, October 1, 2002; 23(10): 1641 - 1646. [Abstract] [Full Text] [PDF]

				S S Coughlin Future challenges for research on diagnostic tests: genetic tests and disease prevention J. Epidemiol. Community Health, May 1, 2002; 56(5): 335 - 336. [Full Text] [PDF]

				S. M. Modell and T. Citrin Ethics Instruction in an Issues-Oriented Course on Public Health Genetics Health Educ Behav, February 1, 2002; 29(1): 43 - 60. [Abstract] [PDF]

				D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF]

				G. Anderson and M. V. Rorty Key Points for Developing an International Declaration on Nursing, Human Rights, Human Genetics and Public Health Policy Nursing Ethics, May 1, 2001; 8(3): 259 - 271. [Abstract] [PDF]

				C. Kwon and P. M. Farrell The Magnitude and Challenge of False-Positive Newborn Screening Test Results Arch Pediatr Adolesc Med, July 1, 2000; 154(7): 714 - 718. [Abstract] [Full Text] [PDF]

				F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF]

				F. P. Perera and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis, March 1, 2000; 21(3): 517 - 524. [Abstract] [Full Text] [PDF]

				R L Zimmern The human genome project: a false dawn? BMJ, November 13, 1999; 319(7220): 1282 - 1282. [Full Text]

				E. Kodish, G. L. Wiesner, M. Mehlman, and T. Murray Genetic Testing for Cancer Risk: How to Reconcile the Conflicts JAMA, January 21, 1998; 279(3): 179 - 181. [Full Text] [PDF]

				G. E. Spiegler and A. G. Motulsky Genetic Screening of Adolescents N. Engl. J. Med., August 28, 1997; 337(9): 639 - 640. [Full Text]